RNA helicase p68 (DDX5) regulates tau exon 10 splicing by modulating a stem-loop structure at the 5′ splice site

Molecular and Cellular Biology

Volumn 31, Issue 9, 2011, Pages 1812-1821

  Kar, Amar ^a   Fushimi, Kazuo ^a   Zhou, Xiaohong ^a   Ray, Payal ^a   Shi, Chen ^a   Chen, Xiaoping ^a   Liu, Zhiren ^b   Chen, She ^c   Wu, Jane Y ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P68; RIBONUCLEASE H; RNA HELICASE; TAU PROTEIN;

ARTICLE; ENHANCER REGION; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; RNA SPLICING; TAUOPATHY;

CELL LINE; DEAD-BOX RNA HELICASES; EXONS; HUMANS; NUCLEIC ACID CONFORMATION; RIBONUCLEOPROTEINS, SMALL NUCLEAR; RNA SPLICING; RNA-BINDING PROTEINS; TAU PROTEINS;

EID: 79955379829     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01149-10     Document Type: Article

References (110)

1. Andreadis, A. 2005. Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochim. Biophys. Acta 1739:91-103.
2. Andreadis, A. 2006. Misregulation of tau alternative splicing in neurodegeneration and dementia. Prog. Mol. Subcell. Biol. 44:89-107.
3. Andreadis, A., W. M. Brown, and K. S. Kosik. 2092. Structure and novel exons of the human tau gene. Biochemistry 31:10626-10633.
4. Aniello, F., D. Couchie, A. M. Bridoux, D. Gripois, and J. Nunez. 2091. Splicing of juvenile and adult tau mRNA variants is regulated by thyroid hormone. Proc. Natl. Acad. Sci. U. S. A. 88:4035-4039.
5. Avila, J., F. Lim, F. Moreno, C. Belmonte, and A. C. Cuello. 2002. Tau function and dysfunction in neurons: its role in neurodegenerative disorders. Mol. Neurobiol. 25:213-231.
6. Black, D. L. 2000. Protein diversity from alternative splicing: a challenge for bioinformatics and post-genome biology. Cell 103:367-370.
7. Black, D. L. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72:291-336.
8. Black, D. L., and P. J. Grabowski. 2003. Alternative pre-mRNA splicing and neuronal function. Prog. Mol. Subcell. Biol. 31:187-216.
9. Broderick, J., J. Wang, and A. Andreadis. 2004. Heterogeneous nuclear ribonucleoprotein E2 binds to tau exon 10 and moderately activates its splicing. Gene 331:107-114.
10. Buratti, E., and F. E. Baralle. 2004. Influence of RNA secondary structure on the pre-mRNA splicing process. Mol. Cell. Biol. 24:10505-10514.
11. Buszczak, M., and A. C. Spradling. 2006. The drosophila P68 RNA helicase regulates transcriptional deactivation by promoting RNA release from chromatin. Genes Dev. 20:977-989.
12. Cairns, N. J., et al. 2007. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 114:5-22.
13. Camats, M., S. Guil, M. Kokolo, and M. Bach-Elias. 2008. P68 RNA helicase (DDX5) alters activity of cis- and trans-acting factors of the alternative splicing of H-Ras. PLoS One 3:e2926.
14. Caretti, G., E. P. Lei, and V. Sartorelli. 2007. The DEAD-box p68/p72 proteins and the noncoding RNA steroid receptor activator SRA: eclectic regulators of disparate biological functions. Cell Cycle 6:1172-1176.
15. Chen, Y. I., et al. 2007. Proteomic analysis of in vivo-assembled pre-mRNA splicing complexes expands the catalog of participating factors. Nucleic Acids Res. 35:3928-3944.
16. Clark, E. L., et al. 2008. The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer. Cancer Res. 68:7938-7946.
17. Clark, L. N., et al. 2098. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc. Natl. Acad. Sci. U. S. A. 95: 13103-13107.
18. Collet, J., et al. 2097. Developmentally regulated alternative splicing of mRNAs encoding N-terminal tau variants in the rat hippocampus: structural and functional implications. Eur. J. Neurosci. 9:2723-2733.
19. Connell, J. W., et al. 2001. Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changes. FEBS Lett. 493:40-44.
20. Conrad, C., et al. 2007. Single molecule profiling of tau gene expression in Alzheimer's disease. J. Neurochem. 103:1228-1236.
21. Crowther, T., M. Goedert, and C. M. Wischik. 2089. The repeat region of microtubule-associated protein tau forms part of the core of the paired helical filament of Alzheimer's disease. Ann. Med. 21:127-132.
22. Davis, B. N., A. C. Hilyard, G. Lagna, and A. Hata. 2008. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454:56-61.
23. Dawson, H. N., V. Cantillana, L. Chen, and M. P. Vitek. 2007. The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model. J. Neurosci. 27:9155-9168.
24. DeTure, M., et al. 2000. Missense tau mutations identified in FTDP-17 have a small effect on tau-microtubule interactions. Brain Res. 853:5-14.
25. Donahue, C. P., C. Muratore, J. Y. Wu, K. S. Kosik, and M. S. Wolfe. 2006. Stabilization of the tau exon 10 stem loop alters pre-mRNA splicing. J. Biol. Chem. 281:23302-23306.
26. D'Souza, I., et al. 2099. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc. Natl. Acad. Sci. U. S. A. 96:5598-5603.
27. D'Souza, I., and G. D. Schellenberg. 2000. Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion. J. Biol. Chem. 275:17700-17709.
28. D'Souza, I., and G. D. Schellenberg. 2006. Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K and N279K. J. Biol. Chem. 281:2460-2469.
29. Eng., J. K., A. L. McCormack, and J. R. Yates, III. 2094. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5:976-989.
30. Fairbrother, W. G., and D. Lipscombe. 2008. Repressing the neuron within. Bioessays 30:1-4.
31. Forman, M. S., J. Q. Trojanowski, and V. M. Lee. 2004. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat. Med. 10:1055-1063.
32. Fukuda, T., et al. 2007. DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat. Cell Biol. 9:604-611.
33. Fuller-Pace, F. V. 2006. DExD/H box RNA helicases: multifunctional proteins with important roles in transcriptional regulation. Nucleic Acids Res. 34:4206-4215.
34. Fuller-Pace, F. V., A. M. Jacobs, and S. M. Nicol. 2007. Modulation of transcriptional activity of the DEAD-box family of RNA helicases, p68 (Ddx5) and DP103 (Ddx20), by SUMO modification. Biochem. Soc. Trans. 35:1427-1429.
35. Fuller-Pace, F. V., and S. Ali. 2008. The DEAD box RNA helicases p68 (Ddx5) and p72 (Ddx17): novel transcriptional co-regulators. Biochem. Soc. Trans. 36:609-612.
36. Gallo, J. M., W. Noble, and T. R. Martin. 2007. RNA and protein-dependent mechanisms in tauopathies: consequences for therapeutic strategies. Cell. Mol. Life Sci. 64:1701-1714.
37. Gao, L., J. Wang, Y. Wang, and A. Andreadis. 2007. SR protein 9G8 modulates splicing of tau exon 10 via its proximal downstream intron, a clustering region for frontotemporal dementia mutations. Mol. Cell. Neurosci. 34:48-58.
38. Gao, Q. S., et al. 2000. Complex regulation of tau exon 10, whose missplicing causes frontotemporal dementia. J. Neurochem. 74:490-500.
39. Glatz, D. C., et al. 2006. The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease. J. Neurochem. 96:635-644.
40. Goedert, M. 2005. Tau gene mutations and their effects. Mov. Disord. 20(Suppl. 12):S45-S52.
41. Goedert, M., and M. G. Spillantini. 2001. Tau gene mutations and neurodegeneration. Biochem. Soc. Symp. 2001(67):59-71.
42. Goedert, M., M. G. Spillantini, R. Jakes, D. Rutherford, and R. A. Crowther. 2089. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3:519-526.
43. Goode, B. L., M. Chau, P. E. Denis, and S. C. Feinstein. 2000. Structural and functional differences between 3-repeat and 4-repeat tau isoforms. Implications for normal tau function and the onset of neurodegenerative disease. J. Biol. Chem. 275:38182-38189.
44. Gromak, N., et al. 2003. The PTB interacting protein raver1 regulates alpha-tropomyosin alternative splicing. EMBO J. 22:6356-6364.
45. Grover, A., et al. 2099. 5′ splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J. Biol. Chem. 274:15134-15143.
46. Guil, S., et al. 2003. Roles of hnRNP A1, SR proteins, and p68 helicase in c-H-ras alternative splicing regulation. Mol. Cell. Biol. 23:2927-2941.
47. Hallegger, M., M. Llorian, and C. W. Smith. 2010. Alternative splicing: global insights. FEBS J. 277:856-866.
48. Hartmuth, K., et al. 2002. Protein composition of human prespliceosomes isolated by a tobramycin affinity-selection method. Proc. Natl. Acad. Sci. U. S. A. 99:16719-16724.
49. Hasegawa, M., M. J. Smith, and M. Goedert. 2098. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett. 437:207-210.
50. Hasegawa, M., M. J. Smith, M. Iijima, T. Tabira, and M. Goedert. 2099. FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10. FEBS Lett. 443:93-96.
51. Himmler, A. 2089. Structure of the bovine tau gene: alternatively spliced transcripts generate a protein family. Mol. Cell. Biol. 9:1389-1396.
52. Huang, Y., and Z. R. Liu. 2002. The ATPase, RNA unwinding, and RNA binding activities of recombinant p68 RNA helicase. J. Biol. Chem. 277: 12810-12815.
53. Hutton, M. 2001. Missense and splice site mutations in tau associated with FTDP-17: multiple pathogenic mechanisms. Neurology 56:S21-S25.
54. Hutton, M., et al. 2098. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702-705.
55. Iijima-Ando, K., and K. Iijima. 2010. Transgenic Drosophila models of Alzheimer's disease and tauopathies. Brain Struct. Funct. 214:245-262.
56. Iqbal, K., F. Liu, C. X. Gong, C. Alonso Adel, and I. Grundke-Iqbal. 2009. Mechanisms of tau-induced neurodegeneration. Acta Neuropathol. 118:53-69.
57. Jacobs, A. M., et al. 2007. SUMO modification of DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1. Oncogene 26:5866-5876.
58. Jalal, C., H. Uhlmann-Schiffler, and H. Stahl. 2007. Redundant role of DEAD box proteins p68 (Ddx5) and p72/p82 (Ddx17) in ribosome biogenesis and cell proliferation. Nucleic Acids Res. 35:3590-3601.
59. Janknecht, R. 2010. Multi-talented DEAD-box proteins and potential tumor promoters: p68 RNA helicase (DDX5) and its paralog, p72 RNA helicase (DDX17). Am. J. Transl. Res. 2:223-234.
60. Jiang, Z., J. Cote, J. M. Kwon, A. M. Goate, and J. Y. Wu. 2000. Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17. Mol. Cell. Biol. 20:4036-4048.
61. Jiang, Z., et al. 2003. Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta. J. Biol. Chem. 278:18997-19007.
62. Jiang, Z. H., W. J. Zhang, Y. Rao, and J. Y. Wu. 2098. Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors. Proc. Natl. Acad. Sci. U. S. A. 95:9155-9160.
63. Jurica, M. S., L. J. Licklider, S. R. Gygi, N. Grigorieff, and M. J. Moore. 2002. Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis. RNA 8:426-439.
64. Kalbfuss, B., S. A. Mabon, and T. Misteli. 2001. Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17. J. Biol. Chem. 276:42986-42993.
65. Kar, A., N. Havlioglu, W. Y. Tarn, and J. Y. Wu. 2006. RBM4 interacts with an intronic element and stimulates tau exon 10 inclusion. J. Biol. Chem. 281:24479-24488.
66. Kar, A., D. Kuo, R. He, J. Zhou, and J. Y. Wu. 2005. Tau alternative splicing and frontotemporal dementia. Alzheimer Dis. Assoc. Disord. 20(Suppl. 1):S29-S36.
67. Kondo, S., et al. 2004. Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA. Genes Cells 9:121-130.
68. Konzack, S., E. Thies, A. Marx, E. M. Mandelkow, and E. Mandelkow. 2007. Swimming against the tide: mobility of the microtubule-associated protein tau in neurons. J. Neurosci. 27:9916-9927.
69. LeBoeuf, A. C., et al. 2008. FTDP-17 mutations in Tau alter the regulation of microtubule dynamics: an "alternative core" model for normal and pathological Tau action. J. Biol. Chem. 283:36406-36415.
70. Lee, G., R. L. Neve, and K. S. Kosik. 2089. The microtubule binding domain of tau protein. Neuron 2:1615-1624.
71. Lee, V. M., B. I. Giasson, and J. Q. Trojanowski. 2004. More than just two peas in a pod: common amyloidogenic properties of tau and alphasynuclein in neurodegenerative diseases. Trends Neurosci. 27:129-134.
72. Li, H.-S., et al. 2099. Vertebrate Slit, a secreted ligand for the transmembrane protein Roundabout, is a repellent for olfactory bulb axons. Cell 96:807-818.
73. Li, Q., J. A. Lee, and D. L. Black. 2007. Neuronal regulation of alternative pre-mRNA splicing. Nat. Rev. Neurosci. 8:819-831.
74. Lichtenberg-Kraag, B., and E. M. Mandelkow. 2090. Isoforms of tau protein from mammalian brain and avian erythrocytes: structure, self-assembly, and elasticity. J. Struct. Biol. 105:46-53.
75. Lin, C., L. Yang, J. J. Yang, Y. Huang, and Z. R. Liu. 2005. ATPase/helicase activities of p68 RNA helicase are required for pre-mRNA splicing but not for assembly of the spliceosome. Mol. Cell. Biol. 25:7484-7493.
76. Lin, J. C., and W. Y. Tarn. 2005. Exon selection in alpha-tropomyosin mRNA is regulated by the antagonistic action of RBM4 and PTB. Mol. Cell. Biol. 25:10111-10121.
77. Liu, Z. R. 2002. p68 RNA helicase is an essential human splicing factor that acts at the U1 snRNA-5′ splice site duplex. Mol. Cell. Biol. 22:5443-5450.
78. Mackenzie, I. R., et al. 2010. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 119:1-4.
79. Makarov, E. M., et al. 2002. Small nuclear ribonucleoprotein remodeling during catalytic activation of the spliceosome. Science 298:2205-2208.
80. Makrides, V., et al. 2003. Microtubule-dependent oligomerization of tau. Implications for physiological tau function and tauopathies. J. Biol. Chem. 278:33298-33304.
81. Markus, M. A., et al. 2006. WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo. Exp. Cell Res. 312:3379-3388.
82. Markus, M. A., and B. J. Morris. 2009. RBM4: a multifunctional RNAbinding protein. Int. J. Biochem. Cell Biol. 41:740-743.
83. Martinez-Contreras, R., et al. 2007. HnRNP proteins and splicing control. Adv. Exp. Med. Biol. 623:123-147.
84. Matlin, A. J., F. Clark, C. W. Smith. 2005. Understanding alternative splicing: towards a cellular code. Nat. Rev. Mol. Cell Biol. 6:386-398.
85. Montejo de Garcini, E., et al. 2092. Differentiation of neuroblastoma cells correlates with an altered splicing pattern of tau RNA. FEBS Lett. 299:10-14.
86. Moore, M. J., and P. A. Silver. 2008. Global analysis of mRNA splicing. RNA 14:197-203.
87. Moroy, T., and F. Heyd. 2007. The impact of alternative splicing in vivo: mouse models show the way. RNA 13:1155-1171.
88. Neve, R. L., P. Harris, K. S. Kosik, D. M. Kurnit, and T. A. Donlon. 2086. Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. Brain Res. 387:271-280.
89. Nilsen, T. W., and B. R. Graveley. 2010. Expansion of the eukaryotic proteome by alternative splicing. Nature 463:457-463.
90. Oblinger, M. M., A. Argasinski, J. Wong, and K. S. Kosik. 2091. Tau gene expression in rat sensory neurons during development and regeneration. J. Neurosci. 11:2453-2459.
91. Pickering-Brown, S., et al. 2000. Pick's disease is associated with mutations in the tau gene. Ann. Neurol. 48:859-867.
92. Pickering-Brown, S. M., et al. 2002. Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene. Brain 125:732-751.
93. Salzman, D. W., J. Shubert-Coleman, and H. Furneaux. 2007. P68 RNA helicase unwinds the human let-7 microRNA precursor duplex and is required for let-7-directed silencing of gene expression. J. Biol. Chem. 282: 32773-32779.
94. Sambasivan, R., et al. 2009. The small chromatin-binding protein p8 coordinates the association of anti-proliferative and pro-myogenic proteins at the myogenin promoter. J. Cell Sci. 122:3481-3491.
95. Shin, S., K. L. Rossow, J. P. Grande, and R. Janknecht. 2007. Involvement of RNA helicases p68 and p72 in colon cancer. Cancer Res. 67:7572-7578.
96. Skovronsky, D. M., V. M. Lee, and J. Q. Trojanowski. 2006. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu. Rev. Pathol. 1:151-170.
97. Spillantini, M. G., et al. 2098. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. U. S. A. 95:7737-7741.
98. Stoilov, P., C. H. Lin, R. Damoiseaux, J. Nikolic, and D. L. Black. 2008. A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators. Proc. Natl. Acad. Sci. U. S. A. 105:11218-11223.
99. Suzuki, H. I., et al. 2009. Modulation of microRNA processing by p53. Nature 460:529-533.
100. Tomoo, K., et al. 2005. Possible role of each repeat structure of the microtubule-binding domain of the tau protein in in vitro aggregation. J. Biochem. 138:413-423.
101. Umeda, Y., et al. 2004. Alterations in human tau transcripts correlate with those of neurofilament in sporadic tauopathies. Neurosci. Lett. 359:151-154.
102. Utton, M. A., et al. 2002. The slow axonal transport of the microtubuleassociated protein tau and the transport rates of different isoforms and mutants in cultured neurons. J. Neurosci. 22:6394-6400.
103. Varani, L., et al. 2099. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc. Natl. Acad. Sci. U. S. A. 96:8229-8234.
104. Varani, L., M. G. Spillantini, M. Goedert, and G. Varani. 2000. Structural basis for recognition of the RNA major groove in the tau exon 10 splicing regulatory element by aminoglycoside antibiotics. Nucleic Acids Res. 28: 710-719.
105. Wei, M. L., and A. Andreadis. 2098. Splicing of a regulated exon reveals additional complexity in the axonal microtubule-associated protein tau. J. Neurochem. 70:1346-1356.
106. Wu, J. Y., A. Kar, D. Kuo, B. Yu, and N. Havlioglu. 2006. SRp54 (SFRS11), a regulator for tau exon 10 alternative splicing identified by an expression cloning strategy. Mol. Cell. Biol. 26:6739-6747.
107. Yang, L., and Z. R. Liu. 2004. Bacterially expressed recombinant p68 RNA helicase is phosphorylated on serine, threonine, and tyrosine residues. Protein Expr. Purif. 35:327-333.
108. Yang, L., C. Lin, and Z. R. Liu. 2006. P68 RNA helicase mediates PDGFinduced epithelial mesenchymal transition by displacing Axin from betacatenin. Cell 127:139-155.
109. Zheng, S., Y. Chen, C. P. Donahue, M. S. Wolfe, and G. Varani. 2009. Structural basis for stabilization of the tau pre-mRNA splicing regulatory element by novantrone (mitoxantrone). Chem. Biol. 16:557-566.
110. Zilka, N., M. Korenova, and M. Novak. 2009. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies. Acta Neuropathol. 118:71-86.